Heart BMJ

FEBRUARY 12, 2024

Introduction Management of heart failure (HF) requires multidisciplinary, pharmacological and non-pharmacological strategies, one component of which is exercise training.

Exercise 40

Exercise Heart Failure Preserved Ejection Fraction Pharmacology 40

Stroke Journal

MARCH 4, 2025

Other rehabilitation strategies that enhance cognitive reserve and pharmacological interventions are discussed about improving the quality of life in survivors. Management techniques reviewed include long-term cognitive health, such as endovascular coiling and surgical clipping.

Hemorrhage 40

Hemorrhage Genetic predisposition Genetic Markers Quality of Life 40

Journal of the American Heart Association

MARCH 7, 2025

BackgroundCardiac myosin inhibitors were recently developed to address the underlying pathophysiology of hypertrophic cardiomyopathy and to improve symptoms and quality of life.

Cardiomyopathy 45

Cardiomyopathy Quality of Life Atrial Fibrillation Pharmacology 45

Journal of Cardiovascular Pharmacology

MARCH 17, 2025

The main objectives were to assess the feasibility of enrollment and adherence to and satisfaction with the hybrid strategy along with health-related quality of life and anxiety level. Quality of life index and anxiety level remained unchanged for both groups during the 30-day follow-up.

Quality of Life 40

Quality of Life Education Document Cardiovascular Disease 40

Journal of Cardiovascular Pharmacology

MAY 9, 2023

In patients with RP who have become colchicine-resistant and glucocorticoid-dependent, IL-1 blockade with rilonacept or anakinra effectively treats recurrences and prevents future flares, and significantly improves quality of life. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Pericarditis 40

Pericarditis Quality of Life Outcomes Article 40

Cardiometabolic Health Congress

AUGUST 30, 2024

Pharmacological Interventions : Use of antihypertensive medications, lipid-lowering agents, and antidiabetic drugs. Overcoming status quo bias and embracing the latest evidence-based practices are essential steps toward delivering high-quality, personalized care in cardiometabolic medicine.

Cardiac Rehabilitation 52

Cardiac Rehabilitation Heart Failure Quality of Life Aortic 52

Cardiometabolic Health Congress

JANUARY 3, 2024

Furthermore, carrying excess weight can also have detrimental effects on mental health as individuals may experience low self-esteem, body image issues, depression, and a reduced quality of life. The Rise of Weight Loss Drugs The rise of weight loss drugs has brought with it a promising solution in the battle against obesity.

Obesity 97

Obesity Diabetes Blood Pressure BMI 97

DAIC

JULY 25, 2024

BioCardia previously confirmed alignment with the United States Food and Drug Administration (FDA) on the design of the 250-patient randomized, controlled trial and the minimum of 12-month primary composite endpoint of all cause death, reduction in major adverse cardiovascular events, and improvement in quality of life.

Heart Failure 111

Heart Failure Quality of Life CMS Reimbursement 111

DAIC

MAY 16, 2024

This plaque narrows the blood vessels and reduces blood flow to the legs and feet, which may significantly impair physical function, walking performance and quality of life. Pharmacological and behavioral-based strategies often increase the smoking cessation rate in people with PAD, however, these strategies are underused.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105

Dr. Sanjay Gupta

MARCH 6, 2022

Pharmacological treatments: These can be divided into 2 groups Medications that improve quality of life (usually by relieving symptoms) and medications that can prolong life. Medications that improve quality of life in heart failure for example include diuretics.

Chronic Disease 40

Chronic Disease Quality of Life Heart Failure Nursing 40

DAIC

MAY 9, 2024

New HCM Guidelines Updated recommendations in the guideline reflect recent evidence about HCM treatment and management including new forms of pharmacologic management; participation in vigorous recreational activities and competitive sports; and risk stratification for sudden cardiac death (SCD) with an emphasis on pediatric patients.

Cardiomyopathy 52

Cardiomyopathy Pediatrics Quality of Life Sudden Cardiac Death 52

Stroke Journal

FEBRUARY 1, 2024

Post-stroke mood disturbances may affect stroke survivors from returning to work, poorer quality of life (QOL), and stroke reoccurrence. Mood disturbances may be treated or prevented by pharmacological therapy, counseling, and education. Approximately 30-50% of post-stroke patients have emotional and mood disturbances (e.g.,

Strokes 40

Strokes Stroke Quality of Life Pharmacology 40

European Journal of Heart Failure

DECEMBER 1, 2024

5+) support is effective in facilitating heart recovery, overall survival, and quality of life. A comprehensive platform of mechanical and pharmacological unloading is key. The objective of the study is to examine whether Impella 5.0/5.5

Cardiogenic Shock 40

Cardiogenic Shock Heart Transplant Outcomes Transplant 40